Download PDF
Thromb Haemost 1990; 63(03): 383-385
DOI: 10.1055/s-0038-1645052
Original Article
Schattauer GmbH Stuttgart

β-TG and Plasma Catecholamines Levels after Sympathetic Stimuli in Hypertensives and Patients with Peripheral Vascular Disease

Maria Catalano
*   The “Centro di Ricerca per la Prevenzione e la Terapia della Patologia Vascolare Periferica”, Clinica Medica Generale, Milano, Italy
,
Umberto Russo
*   The “Centro di Ricerca per la Prevenzione e la Terapia della Patologia Vascolare Periferica”, Clinica Medica Generale, Milano, Italy
,
Sebastiano Belletti
*   The “Centro di Ricerca per la Prevenzione e la Terapia della Patologia Vascolare Periferica”, Clinica Medica Generale, Milano, Italy
,
Fabrizio Colombo
*   The “Centro di Ricerca per la Prevenzione e la Terapia della Patologia Vascolare Periferica”, Clinica Medica Generale, Milano, Italy
,
Armando Belloni
*   The “Centro di Ricerca per la Prevenzione e la Terapia della Patologia Vascolare Periferica”, Clinica Medica Generale, Milano, Italy
,
Gianfranco del Rosso
*   The “Centro di Ricerca per la Prevenzione e la Terapia della Patologia Vascolare Periferica”, Clinica Medica Generale, Milano, Italy
,
Federico Lombardi
**   Patologia Speciale Medica, Università degli Studi di Milano, Osp. L. Sacco, Milano, Italy
,
Arnaldo Libretti
*   The “Centro di Ricerca per la Prevenzione e la Terapia della Patologia Vascolare Periferica”, Clinica Medica Generale, Milano, Italy
› Author Affiliations
Further Information

Publication History

Received 26 April 1989

Accepted after revision 13 February 1990

Publication Date:
30 June 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The influence of the sympathetic nervous system on platelet functions in vivo is still controversial. The aims of our study were to compare the response to various sympathetic stimuli in normal subjects and in patients with essential hypertension (HT) or peripheral vascular disease (PVD) and to evaluate any correlations among plasma levels of catecholamines, beta-thrombo-globulin (β-TG) and platelet factor 4 (PF4). In basal conditions β-TG and PF4 values in the HT patients were higher than those observed in the controls of the same age but lower than those of the PVD patients. Although the different sympathetic stimuli (90° tilting, handgrip, treadmill test, bicycle test) caused a significant increase of the plasma epinephrine (E) and norepinephrine (NE) levels, they did not modify the β-TG and PF4 levels in any of the groups studied. The platelet activation indices, therefore, regardless of the basal values, do not seem to be influenced by sympathetic stimulation.

 

  • References

  • 1 Kaplan KL, Broekman MJ, Lesznik GR, Drillings M. Platelet alpha-granules proteins: studies on release and subcellular localization. Blood 1979; 53: 604-18
    PubMedGoogle Scholar
  • 2 Kaplan KL, Owen J. Plasma levels of β-TG and PF4 as indices of platelet activation in vivo. Blood 1981; 57: 199-202
    PubMedGoogle Scholar
  • 3 Zahavi J, Kakkar VV. β-TG - a specific marker of in vivo platelet release reaction. Thromb Haemostas 1980; 44: 23-9
    PubMedGoogle Scholar
  • 4 Ludlam CA, Cash JD. Studies on the liberation of β-TG, from human platelets in vitro. Br J. Haematol 1976; 33: 239-47
    CrossrefPubMedGoogle Scholar
  • 5 Rasi V. β-TG in plasma: false high values caused by platelet enrichment of the top layer of plasma during centrifugation. Thromb Res 1979; 15: 543-52
    CrossrefPubMedGoogle Scholar
  • 6 Zahavi J, Cella G, Dubiel M, Kakkar VV. The variability of plasma β-TG in healthy individuals. Thromb Haemostas 1978; 40: 565-7
    PubMedGoogle Scholar
  • 7 Ludlam CA. Evidence for the platelet specificity of β-TG and studies on its plasma concentration in healthy individuals. Br J Haematol 1979; 41: 271-8
    CrossrefPubMedGoogle Scholar
  • 8 Zahavi J, Jones NA G, Leyton J, Dubiel M, Kakkar VV. Enhanced in vivo platelet release reaction in old healthy individuals. Thromb Res 1980; 17: 329-36
    CrossrefPubMedGoogle Scholar
  • 9 Baele G, Bogaerts H, Clement D, Pannier R, Barbier F. Platelet activation during treadmill exercise in patients with chronic peripheral arterial disease. Thromb Res 1981; 23: 215-23
    CrossrefPubMedGoogle Scholar
  • 10 Catalano M, Russo U, Libretti A. Plasma β-TG levels and claudication degrees in patients with peripheral vascular disease. Angiology 1986; 37 (05) 339-41
    CrossrefPubMedGoogle Scholar
  • 11 Cella G, Zahavi J, De Haas HA, Kakkar VV. β-Thromboglobulin, platelet production time and platelet function in vascular disease. Br J Haematol 1979; 43: 127-36
    CrossrefPubMedGoogle Scholar
  • 12 Bevan D, Yates CJ P, Dormandy JA, Flute PT. β-Thromboglobulin in peripheral arterial disease. Thromb Diath Haemorrh 1979; 42 (01) 147
    PubMedGoogle Scholar
  • 13 Minar E, Ehringer H. Influence of acetylsalicylic acid on platelet survival time, β-thromboglobulin and platelet factor 4 in patients with peripheral arterial occlusive disease. Thromb Res 1987; 45: 791-802
    CrossrefPubMedGoogle Scholar
  • 14 Van Oost BA, Veldhuyzen BF E, Van Houwelingen HC, Timmermans AP M, Sixma JJ. Tests for platelet changes, acute phase reactants and serum lipids in diabetes mellitus and peripheral vascular disease. Thromb Haemostas 1982; 48 (03) 289-93
    PubMedGoogle Scholar
  • 15 Sobel M, Salzman EW, Davies GC, Handin RI, Sweeney J, Ploetz J, Kurland G. Circulating platelet products in unstable angina pectoris. Circulation 1981; 63 (02) 300-6
    CrossrefPubMedGoogle Scholar
  • 16 Rasi V, Turstila I, Ikkala E. β-Thromboglobulin in acute myocardial infarction. Acta Med Scand 1980; (Suppl. 642) 85-91
    PubMedGoogle Scholar
  • 17 Pumphrey CW, Dawes J. Plasma β-thromboglobulin as a measure of platelet activity. Am J Cardiol 1982; 50: 1258-61
    CrossrefPubMedGoogle Scholar
  • 18 Handin R, McDonough M, Lesch M. Elevation of PF4 in acute myocardial infarction: measurement by radioimmunoassay. J Lab Clin Med 1978; 91 (08) 340-9
    PubMedGoogle Scholar
  • 19 Smitherman TC, Milam M, Woo J, Willerson JT, Frenkel EP. Elevated β-thromboglobulin in peripheral venous blood of patients with acute myocardial ischemia: direct evidence for enhanced platelet reactivity in vivo. Am J Cardiol 1981; 48 (03) 395-402
    CrossrefPubMedGoogle Scholar
  • 20 Levine SP, Lindenfeld J, Brant EJ, Raymond NM, Krentz LS. Increased plasma concentrations of platelet factor 4 in coronary artery disease. Circulation 1981; 64 (03) 626-32
    CrossrefPubMedGoogle Scholar
  • 21 Files JC, Malpass TW, Yee EK, Ritchie JL, Harker LA. Studies of human platelet alpha-granule release in vivo. Blood 1981; 58 (03) 607-18
    PubMedGoogle Scholar
  • 22 Pengo U, Boschello M, Prandoni P, Schiavon R, Bellotto F, Schivazappa L, Dalla VoltaS. Enhanced in vitro release of platelet alpha-granules after acute myocardial infarction. Thromb Haemostas 1985; 54 (02) 544-6
    PubMedGoogle Scholar
  • 23 Taomoto K, Asada M, Kanazawa Y, Matsumoto S. Usefulness of the measurement of plasma β-thromboglobulin in cerebrovascular disease. Stroke 1983; 14 (04) 518-24
    CrossrefPubMedGoogle Scholar
  • 24 Stewart M, Douglas JT, Lowe GO, Prentice CM, Forbes CD. Prognostic value of β-thromboglobulin in patients with transient cerebral ischemia. Lancet 1983; 27: 479-82
    PubMedGoogle Scholar
  • 25 Mehta J, Mehta P. Platelet function in hypertension and effect of therapy. Am J Cardiol 1981; 47: 331
    CrossrefPubMedGoogle Scholar
  • 26 Kjeldsen SE, Gjesdal K, Eide I, Aakesson I, Amundsen R, Foss OP, Leren P. Increased β-thromboglobulin in essential hypertension: interactions between arterial plasma adrenaline, platelet function and blood lipids. Acta Med Scand 1983; 213: 369-73
    PubMedGoogle Scholar
  • 27 Petralito A, Fiore CE, Mangiafico RA, Malatino LS. β-Thromboglobulin plasma levels in different stages of arterial hypertension. Thromb Haemostas 1982; 48 (02) 241
    PubMedGoogle Scholar
  • 28 Catalano M, Belletti S, Russo U, Libretti A. Platelet activation indices in normals, hypertensives and patients with arterial disease. J Hypertens 1987; (Suppl. 05) 133-5
    PubMedGoogle Scholar
  • 29 Yamanishi J, Sano H, Saito K, Furuta Y, Fukuzaki H. Plasma concentrations of platelet-specific proteins in different stages of essential hypertension: interactions between platelet aggregation, blood lipids and age. Thromb Haemostas 1985; 54 (02) 539-43
    PubMedGoogle Scholar
  • 30 Newman KD, Williams LT, Bishopric NH, Lefkowitz RJ. Identification of alpha adrenergic receptors in human platelets by (3H)dihydroergocryptine binding. J Clin Invest 1978; 61: 395-403
    CrossrefPubMedGoogle Scholar
  • 31 Huang EM, Detwiler TC. Characteristics of the synergistic actions of platelet agonists. Blood 1981; 57: 685-8
    PubMedGoogle Scholar
  • 32 Green LH, Seroppian E, Handin RI. Platelet activation during exercise induced myocardial ischemia. N Engl J Med 1980; 302: 193-7
    CrossrefPubMedGoogle Scholar
  • 33 Mathis PC, Wohl H, Wallach S, Engler RL. Lack of release of platelet factor 4 during exercise induced myocardial ischemia. N Engl J Med 1981; 304: 1275-8
    CrossrefPubMedGoogle Scholar
  • 34 Hughes AS B, Ilsley CD, Wilkinson L. Platelet activation during exercise induced myocardial ischemia. Thromb Res 1982; 26: 425-30
    CrossrefPubMedGoogle Scholar
  • 35 Stratton JR, Malpass TW, Ritchie JL, Pfeifer HA, Harker LA. Studies of platelet factor 4 and β-thromboglobulin release during exercise: lack of relationship to myocardial ischemia. Circulation 1982; 66 (01) 33-43
    CrossrefPubMedGoogle Scholar
  • 36 Mehta J, Mehta P. Comparison of platelet function during exercise in normal subjects and coronary artery disease patients: potential role of platelet activation in myocardial ischemia. Am Heart J 1982; 103: 49-53
    CrossrefPubMedGoogle Scholar
  • 37 Baele G, Bogaerts H, Rasquin K, Clement DL. Lack of platelet activation during a standardized treadmill exercise in normal healthy subjects. Thromb Haemostas 1983; 50 (01) 219
    PubMedGoogle Scholar
  • 38 Myreng Y, Lande K, Kjeldsen SE, Eide I, Grendahl H, Gjesdal K. Increase in β-thromboglobulin during exercise. Thromb Res 1987; 48: 111-5
    CrossrefPubMedGoogle Scholar
  • 39 De Caterina R, Gazzetti P, Mazzone A, Marzilli M, L’Abbate A. Platelet activation in angina at rest. Eur Heart J Evidence by paired measurement of plasma β-TG and PF4. 1988; 9: 913-22
    CrossrefPubMedGoogle Scholar
  • 40 Marcella JJ, Nichols AB, Johnson LL, Owen J, Reison DS, Kaplan KL, Cannon PJ. Exercise-induced myocardial ischemia in patients with coronary artery disease: lack of evidence for platelet activation or fibrin formation in peripheral venous blood. J Am Coll Cardiol 1983; 1 (05) 1185-93
    CrossrefPubMedGoogle Scholar
  • 41 Bruce RA. Multistage treadmill test of submaximal and maximal exercise. In: Exercise Testing and Training of Apparently Healthy Individuals: a Handbook for Physicians American Heart Association; New York: 1972. Appendix B
  • 42 Ludlam CA, Moore S, Bolton AE, Pepper DS, Cash JD. The release of a human specific protein measured by radioimmunoassay. Thromb Res 1975; 6: 543-8
    CrossrefPubMedGoogle Scholar
  • 43 Achilli A, Perego C, Ponzio F. Application of the dual cell coulometric detector: a method for assaying monoamines and their metabolites. Anal Biochem 1984 15.
    PubMedGoogle Scholar
  • 44 Hjemdal P. Catecholamine measurement by high performance liquid cromatography. Am J Physiol 1984; 247: 13-20
    PubMedGoogle Scholar